Crossmark

Tocilizumab as a possible cause of ischemic colitis

Published Print: 2021-05

Authors

Forneiro Pérez, Rocío

Dabán López, Pablo

Zurita Saavedra, María Sol

Hernández García, María Dolores

Mirón Pozo, Benito
License Information

Text and Data Mining valid from 2021-05-01

Text and Data Mining valid from 2021-05-01
More Information

This article is maintained by: Elsevier

Article Title: Tocilizumab as a possible cause of ischemic colitis

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2020.07.011

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2020.07.016

Content Type: article

Copyright: © 2020 Elsevier España, S.L.U. All rights reserved.

Document is current